Back to Journals » Neuropsychiatric Disease and Treatment » Volume 14

New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab

Total article views   Abstract views HTML views PDF downloads Totals
10,410 Dovepress* 7,444 855+ 1,445 8,299
PubMed Central* 0 2,111 742 2,111
Totals 7,444 2,966 2,187 10,410
*Since 23 April 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 1 0 0 1 2

View citations on PubMed Central and Google Scholar